Zura Bio (ZURA) Institutional Ownership → Invest in the 'Trojan Horse' of Alzheimer's Treatment (From Behind the Markets) (Ad) Free ZURA Stock Alerts $6.00 +0.81 (+15.61%) (As of 05/16/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Zura Bio (NASDAQ:ZURA)CurrentInstitutional OwnershipPercentage61.14%Number ofInstitutional Buyers(last 12 months)13TotalInstitutional Inflows(last 12 months)$84.15MNumber ofInstitutional Sellers(last 12 months)0 Get ZURA Insider Trade Alerts Want to know when executives and insiders are buying or selling Zura Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ZURA Institutional Buying and Selling by Quarter Ad Porter & CompanyWhat’s Really Next for America…Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now. Zura Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/15/2024 Affinity Asset Advisors LLC450,009$1.16M0.1%N/A1.044% 2/15/2024 Forefront Analytics LLC21,229$99K0.0%+46.8%0.049% 2/13/2024 Armistice Capital LLC1,824,000$8.52M0.1%+15.4%4.233% 11/15/2023 Armistice Capital LLC1,580,000$10.43M0.2%+66.3%3.667% 11/14/2023 Lynx1 Capital Management LP9,917$65K0.0%N/A0.023% 11/13/2023 Eisler Capital US LLC100,000$660K0.0%N/A0.232% 11/13/2023 Silverarc Capital Management LLC404,040$2.67M0.8%+152.5%0.938% 11/8/2023 Forefront Analytics LLC14,464$95K0.1%N/A0.034% 10/24/2023 Bank of New York Mellon Corp33,973$224K0.0%N/A0.079% 10/24/2023 Raymond James & Associates77,356$511K0.0%+14.0%0.180% 8/15/2023 Silverarc Capital Management LLC160,000$1.31M0.4%N/A0.591% 8/15/2023 Suvretta Capital Management LLC2,850,000$23.37M1.2%N/A10.536% 8/14/2023 Great Point Partners LLC3,295,000$27.02M5.3%N/A12.181% 8/14/2023 Deep Track Capital LP2,523,000$20.69M1.0%N/A5.855% 8/10/2023 Monashee Investment Management LLC240,000$1.97M0.5%N/A0.887% 8/4/2023 American International Group Inc.3,649$30K0.0%N/A0.013% 7/25/2023 Raymond James & Associates67,875$557K0.0%N/A0.251% (Data available from 1/1/2016 forward) ZURA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ZURA shares? During the previous two years, 13 institutional investors and hedge funds held shares of Zura Bio. The most heavily invested institutionals were Great Point Partners LLC ($27.02M), Suvretta Capital Management LLC ($23.37M), Deep Track Capital LP ($20.69M), Armistice Capital LLC ($8.52M), Silverarc Capital Management LLC ($2.67M), Monashee Investment Management LLC ($1.97M), and Affinity Asset Advisors LLC ($1.16M).Learn more on ZURA's institutional investors. What percentage of Zura Bio stock is owned by institutional investors? 61.14% of Zura Bio stock is owned by institutional investors. Learn more on ZURA's institutional investor holdings. Which institutional investors have been buying Zura Bio stock? Of the 13 institutional investors that purchased Zura Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Great Point Partners LLC ($3.30M), Suvretta Capital Management LLC ($2.85M), Deep Track Capital LP ($2.52M), Armistice Capital LLC ($874K), Affinity Asset Advisors LLC ($450.01K), Silverarc Capital Management LLC ($404.04K), and Monashee Investment Management LLC ($240K). How much institutional buying is happening at Zura Bio? Institutional investors have bought a total of 10,882,173 shares in the last 24 months. This purchase volume represents approximately $84.15M in transactions. Related Companies: ABOS Major Shareholders INMB Major Shareholders OPT Major Shareholders CGEN Major Shareholders KOD Major Shareholders ELEV Major Shareholders IPHA Major Shareholders ADVM Major Shareholders XFOR Major Shareholders IPSC Major Shareholders This page (NASDAQ:ZURA) was last updated on 5/17/2024 by MarketBeat.com Staff From Our PartnersInvest in the "Trojan Horse" of Alzheimer's TreatmentBehind the MarketsObama’s Forever Term [exposed]Porter & CompanyGold Set to EXPLODE!Gold Safe ExchangeThe 1,000X Crypto PlaybookTrue Market InsidersCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressWhy Is Gold On a MASSIVE rally? Huge AlertsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zura Bio Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.